GlassScriptPhysician profile
Angela A Adomako
NPI 1821399411
$2,120.94
in general payments reported to CMS, 2019-2025
28 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $259 · 2021: $355 · 2022: $341 · 2023: $437 · 2024: $179 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $359.56 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Exeltis, USA INC. | $192.47 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $185.51 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $177.10 | 2023-2025 | |
| Biogen, INC. | $159.01 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $156.97 | 2023-2025 | Veozah |
| Organon LLC | $105.29 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $101.51 | 2020-2024 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $81.74 | 2021-2024 | Paragard T 380a |
| Lupin INC. | $79.32 | 2019-2020 | |
| Avion Pharmaceuticals | $62.66 | 2020-2022 | |
| Ethicon US, LLC | $61.99 | 2021-2023 | Ethicon, Evarrest |
| Pfizer INC. | $48.62 | 2022-2024 | |
| Shield Therapeutics INC | $47.78 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $41.95 | 2019-2023 | Aptima |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $34.41 | 2021-2022 | |
| Allergan, INC. | $26.67 | 2019-2020 | |
| Optumhealth Care Solutions, LLC | $23.35 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Sanofi Pasteur INC. | $22.95 | 2019 | |
| Sumitomo Pharma America, INC. | $22.21 | 2024 | Myfembree |
| Agile Therapeutics, INC. | $19.43 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.06 | 2020 | |
| Mission Pharmacal Company | $16.80 | 2020 | |
| Smith+Nephew, INC. | $16.56 | 2021 | |
| Aspira Women'S Health INC | $15.86 | 2024 | Ova1 |
| Kesin Pharma Corporation | $15.74 | 2023 | Likmez |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.44 | 2019 | |
| Evofem Biosciences, INC. | $13.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Adomako listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.